Search results

Genzyme is currently trading at a premium to the $69 per share cash offer: http://10xreturn.com/stock_center/merger... However it sounds as if "Sanofi will eventually have to raise its offer, already rejected by Genzyme a month ago" and that a price somewhere in the range of $75 per share...